Richard J. Rubino
2016
In 2016, Richard J. Rubino earned a total compensation of $1.4M as Chief Financial Officer, Secretary at Aerie Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $180,000 |
|---|---|
| Option Awards | $711,968 |
| Salary | $387,300 |
| Stock Awards | $166,900 |
| Total | $1,446,168 |
Rubino received $712K in option awards, accounting for 49% of the total pay in 2016.
Rubino also received $180K in bonus, $387.3K in salary and $166.9K in stock awards.
Rankings
In 2016, Richard J. Rubino's compensation ranked 6,437th out of 14,075 executives tracked by ExecPay. In other words, Rubino earned more than 54.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,437 out of 14,075 | 54th |
Division Manufacturing | 2,377 out of 5,489 | 57th |
Major group Chemicals And Allied Products | 778 out of 1,895 | 59th |
Industry group Drugs | 594 out of 1,538 | 61st |
Industry Biological Products, Except Diagnostic Substances | 109 out of 279 | 61st |
Source: SEC filing on April 27, 2017.
Rubino's colleagues
We found three more compensation records of executives who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2016.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019